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Abstract
An in vivo, non-invasive technique for gene silencing by RNA interference (RNAi) in the snail, Biomphalaria glabrata, has
been developed using cationic polymer polyethyleneimine (PEI) mediated delivery of long double-stranded (ds) and small
interfering (si) RNA. Cellular delivery was evaluated and optimized by using a ‘mock’ fluorescent siRNA. Subsequently, we
used the method to suppress expression of Cathepsin B (CathB) with either the corresponding siRNA or dsRNA of this
transcript. In addition, the knockdown of peroxiredoxin (Prx) at both RNA and protein levels was achieved with the PEI-
mediated soaking method. B. glabrata is an important snail host for the transmission of the parasitic digenean
platyhelminth, Schistosoma mansoni that causes schistosomiasis in the neotropics. Progress is being made to realize the
genome sequence of the snail and to uncover gene expression profiles and cellular pathways that enable the snail to either
prevent or sustain an infection. Using PEI complexes, a convenient soaking method has been developed, enabling
functional gene knockdown studies with either dsRNA or siRNA. The protocol developed offers a first whole organism
method for host-parasite gene function studies needed to identify key mechanisms required for parasite development in
the snail host, which ultimately are needed as points for disrupting this parasite mediated disease.
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Introduction
Biomphalaria glabrata is an intermediate snail host that transmits
the digenean platyhelminth parasite, Schistosoma mansoni, in the
Western Hemisphere. This snail host is easily maintained in the
laboratory outside of its natural environment and, therefore, serves
as a useful model organism for conducting studies aimed at
unraveling the complex biology that underlies the snail’s
relationship with the schistosome parasite.
Schistosomiasis, the disease caused by the parasite, is prevalent in
several countries of the developing world where it is estimated that
at least 200 million people are chronically infected [1,2]. Significant
progress is being made towards the identification of genes that
governthesnail/schistosome interaction.Accordingly,severalgenes
that are either up or down regulated in the snail, early after parasite
infection have now been identified [3,4,5]. Among these are genes
involved in innate defense and stress response. A genome project for
B. glabrata is also near completion [6]. It is hoped that all these
advances will lead eventually to the development of novel tools for
halting infection at the snail stage of the parasite’s life cycle. For this
disease transmission blocking strategy to come to fruition, however,
we need a better understanding of what genes/cellular pathways in
the snail host can be interfered with to bring about subsequent
disruption of the parasite’s development.
To investigate what gene expression and/or molecular pathways
are involved in the snail host/parasite relationship, either enabling
or disabling a viable schistosome infection, the technology of RNA
interference (RNAi) to specifically silence gene expression in the
snail host should help to uncover genes/pathways (in the snail host)
that are essential for schistosome development. Fundamentally, it is
also possible to envision that this technology might help us to
identify conserved molecular pathways that are utilized by the
parasite for its survival in both snail and definitive hosts, providing
us with an alternative approach towards the identification of new
targets for either drug or vaccine development.
All previous studies that have reported successful gene -silencing
by RNAi technology in mollusks have been accomplished by an
injectionapproach.Forinstance,in2006byJiangetal.[7]wereable
to knockdown the expression of the snail defense lectin gene, FREP
2 by directly injecting the corresponding dsRNA of this molecule
into the snail hemolymph. Similarly, in another pulmonate
gastropod, Lymnaea stagnalis, the injection of dsRNA corresponding
to the transcript for nitric oxide synthase in this pond snail was
shown to cause the reductionin expressionof this gene, affecting the
feeding behavior of treated snails [8]. Both these studies paved the
way in showing that a post-transcriptional gene silencing (PTGS)
mechanism, mediated by RNAinterference,was indeed operational
in freshwater snails, as had been extensively shown in other
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ortholog of Macrophage Migration Inhibitory Factor (MIF) was
demonstrated at the protein level by injecting the corresponding
dsRNA of this molecule into the snail, making this the first time that
RNAi technology has been shown to suppress protein function in
this snail [9]. In the very few RNAi gene-silencing studies that have
been performed in mollusks only one thus far has used siRNA, not
dsRNA, for mediating the suppression of specific gene expression.
Thusinthisrecentstudy,Hanningtonetal.[4] wereabletoshowthe
knockdown of the protein expression of FREP 3 with a concomitant
increase in snail susceptibility, demonstrating the functional role of
this gene in snail innate immunity.
Since the discovery was made several years ago of the existence
of a dsRNA mediated PTGS pathway in the cell, the knockdown
of specific genes, using either their corresponding dsRNA or
siRNA, to study gene-function has grown exponentially. In
schistosomes, for example, the technique has now been used
widely to demonstrate the importance of several key genes whose
function enables optimum development of larval and adult worms
[10,11]. Furthermore, key parasite enzymes belonging to this
gene-silencing network are being cloned and characterized [12].
Contrary to these significant milestones that have been achieved in
the parasite, in the snail host, however, virtually no information
exists on how this PTGS pathway operates to regulate gene
expression. One exception to this paucity of data is the recent
identification and mapping, by fluorescent in situ hybridization
(FISH), of the B. glabrata homolog of P-element induced wimpy
testis, piwi, a protein that is involved in siRNA mediated silencing
of mobile elements in germ cells [13].
Polyethylenimine (PEI) is a cationic polymer that has been widely
used as a carrier for the delivery of DNA, dsRNA and proteins into
cells [14,15,16]. Because the snail secretes mucus, a complex high
molecular weight protein glycoconjugate substance that is used for
locomotion, as well as forming a natural protective barrier around
the organism [17], it is difficult to deliver nucleic acids in solution
directly into mollusks. In order to deliver dsRNA through the
negatively charged mucus into the snail, we used PEI as a carrier.
Linear (jPEI) and non-linear (branched) PEIs were tested for
delivery. The decision to evaluate PEI as a possible carrier for the
delivery of dsRNA, or siRNA, into the snail was based on prior
experience of using this cationic matrix for separating small
oligonucleotides [18]. Furthermore, the synthetic PEI polymer has
been shown to be a good non-viral delivery system for studying
therapeutic siRNA mediated gene silencing in several animal
models. The advantage of using PEI is that the complex that is
formed with siRNA is a nanoparticle that is protected from
degradation (reviewed by Gunther et al) [19]. Initially, the PEI
delivery method for the snail was optimized with ‘mock’ fluorescent
siRNA. Then the selected method was used to evaluate specific
knockdown, in a ‘proof of principle’ experiment, of transcripts
encoding B. glabrata homologs of Cathepsin B (CathB) [20] and
peroxiredoxin (Prx) [21]. Using siRNA and dsRNA corresponding
to these genes, in combination with linear (jet) PEI, we were able to
show specific knockdown of these transcripts in the snail host.
Materials and Methods
Snails
Juvenile B. glabrata snails of the NMRI stock (2–3 mm in
diameter) were used for the study. The snails were maintained in
de-chlorinated tap water at room temperature and fed on
Romaine lettuce as previously described [22,23]. Before either
siRNA or dsRNA delivery, snails were kept overnight in sterile
H2O without feeding.
RNA isolation and dsRNA preparation
RNA was isolated from the whole snail as previously described
[24]. To prepare dsRNA for the Prx (Acc. No. FJ176942) and
CathB (Acc.no. EU035711) transcripts, we designed primers
correspondingtothetranscriptsequencethatadditionallycontained
sequences of T7 polymerase in cis. Forward and reverse primer
sequences were as follows: (Prx forward primer; spanned position
162–173) 59-taatacgactcaccCGTCATTTCTAA-39, (Prx reverse
primer; spanned position 539–550) 59-taatacgactcaccCTTT-
GGGGTCAA-39, (CathB forward primer; spanned position 381–
392) 59-taatacgactcaccATGACTGACAGA-39 and (CathB reverse
primer; spanned position 851–862) 59-taatacgactcaccTT-
CACTGCGTGT-39. In this study dsRNA (Myo dsRNA) for
myoglobin (Acc.no. U89283) was also prepared and used as mock
dsRNA control. The myoglobin primers utilized for dsRNA
preparation were as follows: forward primer (spanned position
1229–1240) 59-taatacgactcaccGGCAAAAAGAAC-39 and reverse
primer (spanned position 3112–3123) 59-taatacgactcaccAAGAG-
CACTTTC-39.Theprimers(forward and reverse)weredesigned to
encompass two contiguous exons of the myoglobin transcript [25].
To prepare DNA templates for dsRNA synthesis, cDNA made by
using total RNA from the whole snail, as previously described [26]
was amplified by PCR for 30 cycles with the following conditions:
denaturation at 95uC for 30 seconds, annealing at 55uC for
30 seconds, and extension at 72uC for 1 minute, for 30 cycles.
Amplicons of the expected size (397 bp) encompassing positions
161 bp to 558 bp of the BS-90 stock Prx sequence (accession
no. FJ176942, [21]) were purified by using either ‘gene clean’
(MPBIO, Solon, OH) or by using a Sephacryl S-200 microspin
column (GE Healthcare, UK) according to the manufacturer’s
instructions. Purified templates were examined qualitatively by
agarose gel electrophoresis in TBE buffer as previously described
[24] and quantified by a NanoDrop 1000 Spectrophotometer
(Thermo Scientific). Templates (cDNA) used for dsRNA synthesis
were stored at 220uC in sterile H2O until they were required.
AmpliconssynthesizedforCathBandMyotemplateswerepurified,
examined quantitatively and re-suspended as described above.
Author Summary
Freshwater snails are important in the transmission of
schistosomiasis. As part of an integral control effort to
combat the spread of schistosomiasis new intervention
tools are being sought. One method is to interrupt the
transmission of the causative schistosome parasite during
the intra-molluscan phase of its development. Gene-
silencing technology involving the use of dsRNA have
used an injection route to disrupt gene translation in the
Schistosoma mansoni snail host, Biomphalaria glabrata in
an effort to investigate how inhibition of various
transcripts can affect the dynamics of the snail/parasite
interaction. These studies have been helpful in showing us
that a gene-silencing pathway that uses dsRNA indeed
exists in snails but the injection method previously utilized
is impractical, especially when working with juvenile snails.
To make the use of gene silencing technology more widely
applicable to functional gene studies in snails, we have
developed a more convenient soaking method that uses a
cationic carrier polyethylene amine (PEI) to deliver dsRNA
or siRNA into juvenile snails. Using this method we show
the successful knockdown at both RNA and protein levels
of the B. glabrata peroxiredoxin (Prx) gene. The method
was also evaluated for silencing the Cathepsin B (CathB)
gene in the snail.
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from above at a final concentration 20 ng/ml. After denaturing the
template for 5 min at 65uC followed by snap -freezing on ice, the
following was added to the template on ice in a final volume of
50 ml, 56 transcription buffer (Promega, WI), 2.5 mM rNTPs,
100 mM DTT, 2 ml (80 units) Rnasin (Promega, WI), and 1 ml (19
units) T7 polymerase. Samples were incubated for 2 hrs at 37uC
before adding RNAase free DNAase (4 units, RQI, Promega WI),
and incubating for a further hour to remove the DNA template.
Reactions were inactivated with 1 ml 0.5 M EDTA (pH 8.0),
phenol: isoamyl alcohol/chloroform extracted and precipitated
with wheat germ transfer RNA (overnight at 220uC) in 2.56
volumes of Ethanol. The dsRNA was recovered by centrifugation
at 10,0006g for 15 min at 4uC, and the pellet was washed once in
75% ethanol then air-dried. The dried pellet was re-suspended in
sterile de-ionized distilled (dd) H20. The solubilized dsRNA was
examined, qualitatively by agarose gel electrophoresis, purified by
‘gene-clean’ (MPBIO, Solon, OH) according to the manufactur-
er’s instructions, quantified by using a Nanodrop spectrophotom-
eter, and stored at 270uC until required.
Two small inhibitory RNAs (siRNAs) for the CathB transcript;
CathB1 and CathB2 were designed Silencer Select Custom Designed
siRNAs (http://www5.appliedbiosystems.com/tools/sirna/). Both
the CathB siRNAs utilized were synthesized by Applied Biosystems.
CathB1 and CathB2 siRNAs spanned the CathB gene coding DNA
position 94–112 (propeptide C1 region) targeting the sequence 59-
GCGATGCAGAGATCTTCTA93 and position 850–868 (catalyt-
ic region) targeting the sequence 59-GACACGCAGTGAAGAT-
CAT-39, respectively. In order to reduce off-target effects, the
selectedtargetsequencesshowednomatchwithanyotherB.glabrata
and S. mansoni sequences as assessed by Silencer Select Custom
Designed siRNAs using their ‘BLAST and Filter’ function. In
addition, Silencer Negative control siRNA#1 was also provided by
the manufacturer (Ambion, ABI) and used as negative control.
Sequence information for accompanying ‘mock’ siRNAs was not
provided by the manufacturer. However, according to the
manufacturer’s instructions, these ‘mock’ siRNAs do not target
any gene product. Silencer Negative Control siRNAs are validated
for use in human, mouse, and rat cells, and have been functionally
tested for producing minimal effects on cell proliferation and
viability. Supplied with the ‘Cath B gene specific’ siRNAs, the
‘mock’siRNA wasutilized inall assaysto determine the efficiency of
the CathB siRNA/PEI transfection, and to rule out non-specific
effects of siRNA delivery into the snails. ‘Fluorescence siRNA’ sold
as ‘block it’ Alexa 555 (Invitrogen, Life Technologies) was used in
this study. According to the manufacturer, the Alexa 555 siRNA
sequence is not homologous to any known gene and uptake of this
fluorescent siRNA was assessed qualitatively by fluorescent
microscopy according to the manufacturer’s instructions. Each
snailtreatedwiththefluorescentlabeled-siRNAwaskeptinthedark
throughout the experimental procedure. Although siRNA and
dsRNA are, technically both double-stranded RNA, the current
convention is to classify them according to the length of nucleotide
sequence, with longer oligonucleotides (.21–23 nucleotides)
referred to as dsRNA and shorter ones known as siRNA ‘small
interfering RNA’.
PEI mediated delivery of siRNA and dsRNA
The linear PEI commercially sold as Jet PEI (jPEI molecular
weight 22 kDa) was purchased fromPolyPlus (France) and branched
PEI (bPEI) with average molecular weight of 25 kDa was purchased
from Sigma-Aldrich (MO, USA) Both reagents were kept at 4uC
until required. For RNA delivery, we combined the dsRNA (120 ng)
with PEI (93.8 ng of linear or branched) to obtain the complex at a
PEInitrogen/Nucleicacidphosphate(N/P)ratioof6[27].Aresidue
weight of 43 for PEI and 330 for siRNA was used for calculating the
required amounts of PEI and siRNA or dsRNA.
The required amount of siRNA (775 ng) or dsRNA (120 ng)
was diluted to 250 ml of sterile ddH2O in a microcentrifuge tube.
The corresponding amount of PEI was also diluted to 250 mli n
sterile ddH2O in a separate tube. This PEI solution was added to
the tube containing the dsRNA (or siRNA) followed by immediate
vortexing for 10 sec. The mixture (PEI plus dsRNA) was allowed
to incubate to form nanoparticles at room temperature for 30 min
before placing washed snails into the mixture. After placing the
snails in the tubes the samples were mixed gently and the caps
were closed. Using a hypodermic needle, holes were punched into
the caps, and samples were kept at room temperature until the end
of the experiment (routinely 72 hrs but also longer for up to 4
days). Snails (6–8 snails for each experiment) were incubated
individually in the mixture, and all experimental sets were done in
duplicate. Six separate biological replicates using dsRNA/PEI and
5 with siRNA/PEI complexes were performed in total. Because
the snails had a tendency to initially crawl out of the PEI/dsRNA
mixture, tubes were checked periodically to make sure that snails
remained in the solution. Of the two carriers, snails were observed
to crawl less frequently out of the linear than branched PEI,
consequently we used jPEI for all subsequent specific gene-
silencing experiments conducted herein. For each experiment,
controls were set up as follows: normal untreated snails, control
snails incubated in either dsRNA or siRNA alone, mock Myo
dsRNA, mock siRNA (negative control siRNA supplied by the
manufacturer), mock siRNA/PEI, and PEI only control. At the
end of the experiment, snails were removed from the mixture,
washed in sterile H2O and either processed immediately for RNA
or protein isolation. Snails for RNA isolation were stored either in
the RNA isolating reagent and stored at 220uC until required.
Survival of PEI treated snails
Snails (2 to 3 mm in diameter) incubated as described above in
either linear or branched PEI (n=117) for up to 4 days were
monitored daily for mortality compared to normal untreated snails
(n=29).
Microscopy
To determine the uptake of PEI/fluorescent siRNA nanopar-
ticles by microscopy, the outer shell of each snail was removed and
the remaining whole body was rinsed twice in sterile water before
viewing under the light microscope (magnification610). The same
image was then examined for fluorescence (green filter). Images
were captured using the advanced SPOT camera imaging
software (Diagnostic Instruments Inc. Sterling Heights, MI).
Fluorescent signal in tissues was detected qualitatively (as presence
or absence of fluorescence) from the snail tissue samples.
Gene expression analysis
To monitor the expression of Prx or CathB genes after dsRNA/
siRNA treatment in individual snails, total RNA was extracted
from the whole snail using RNAzol RT (Molecular Research
Center, Inc) following the manufacturer’s instructions. With this
method, all contaminating residual DNA was eliminated as
previously described [26]. Quantitative real-time PCR (qPCR)
was performed using Brilliant II SYBR green QPCR master mix,
in a one-step reaction (Stratagene, Agilent) according to the
manufacturer’s instructions and run by using the ABI7300 Real
Time PCR System (Applied Biosystems). Twenty-five microliters
of each qPCR mixture contained 80 ng RNA, 12.5 ml Brilliant
SYBR green PCR Master Mix, 200 nM of each gene specific
RNAi Suppression in B. glabrata by Soaking
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concentrations for each assay were determined after optimization.
In order to avoid the possibility of falsely amplifying any of the
original dsRNA/siRNA that was applied, specific primers (forward
and reverse) were designed outside the region used to synthesize
the original interfering dsRNA product. For Prx, primers were:
Prx-F 59-ATGGCATCCTCTCTGCAAACCGGG-39, Prx-R 59-
TTAGAGTTCATCGTTAGATTGC-39, CathB-F 59-AGCAA-
CACCATTCCACATC-3-9 and CathB-R 59-ATAGCCTCCGT-
TACATCC-39. To assess the degree of knockdown achieved,
primers (F 59-GTCTCCCACACTGTACCTATC-39,R5 9-
CGGTCTGCATCTCGTTTT -39) for the housekeeping gene
actin; Acc.no CO501282 [28] were used as the endogenous
standard for normalization. Additional controls for verifying the
specificity of gene knockdown included; 1) dsRNA or siRNA
alone, 2) PEI alone and 3) Myo dsRNA 4) buffer alone. Three
technical replicates of qPCR were performed with two internal
controls to assess both potential genomic DNA contamination (no
reverse transcriptase added) and purity of the reagents used (no
template added). As indicated above, the knockdown experiment
was repeated multiple times (56) for CathB siRNA, and (66) for
CathB dsRNA and Prx dsRNA (n=5–6) as independent biological
replicates, and by two different investigators. The difference in
gene transcript levels were calculated by the DDCt method [29]
using the actin housekeeping gene to normalize the quantification
of targets. For graphical representation, the DDCt values were
normalized to controls and expressed as the percentage difference.
Protein preparation and analysis using enzyme-linked
immunosorbent assay (ELISA from juvenile snail
hepatopancreas
Since previous studies have shown that the hepatopancreas is
the major location of Prx in B. glabrata, soluble protein extracts
from individual juvenile snails were prepared from this tissue [21].
Using a sharp scalpel blade, under a dissecting microscope, half of
the hepatopancreas was immediately homogenized on ice in sterile
PBS (pH 7.5) containing a cocktail of protease and phosphotase
inhibitors (Sigma-Aldrich). Soluble protein was isolated from the
homogenate as previously described [21]. The remaining dissected
tissue (from each snail) was snap frozen in liquid nitrogen and
processed for RNA isolation as described above. To determine
whether the PEI mediated Prx dsRNA-soaking method would
successfully produce concomitant knockdown of corresponding
protein in the snail, changes occurring in the amount of Prx
between either experimental or control snails were measured
quantitatively by ELISA titre using previously described mouse
polyclonal antibody prepared against B. glabrata recombinant Prx
[21]. Since only limited amount of protein material was available
from the multiple number of tissue samples processed, we found
using ELISA instead of Western Blots [30] to determine the degree
of knockdown at the protein level to be more practical, less labor
intensive, and also cost-effective. For ELISA assays, 100 ml per
well of 10 mg/ml of soluble protein in coating buffer (100 mM
bicarbonate/carbonate buffer, pH 9.6) was coated in a Max-
iSorpflat-bottom 96 well plate (Nunc) at 37uC overnight, then
unbound (excess) proteins were washed out 3 times with washing
buffer (0.01% gelatin, 0.05% BSA, 0.05% Tween 20 in 100 mM
phosphate buffer saline [PBS], pH. 7.2). The remaining binding
sites (that would yield false positive results) were blocked by using
1% BSA in PBS at 37uC for 30 min, then washed (36) in washing
buffer as described above. Subsequently, 10-fold dilution (ELISA
titres varied from 100–204,800) of antibody either polyclonal
antibody of Prx or CathB (100 ml/well) was added into each well
and incubated at 37uC for 1 hr. After washing, each well was
incubated with donkey anti-rabbit IgG (H&L) HRP (Promega,
MA) for Cath B or goat anti-mouse IgG-HRP (Jackson
ImmunoResearch Laboratory, PA) for Prx according to the
Figure 1. Snail organs transfected with the jPEI/fluorescent
siRNA nanoparticles visualized by light and fluorescence
microscopy. Panels A and C: Images of hepatopancreas and ovotestis
regions of juvenile snails that were soaked either in jPEI/Alexa 555
siRNA for either 24 or 72 hrs viewed without fluorescence (106
magnification). Panels B and D: Images of the hepatopancreas and
ovotestis tissues shown in panels A and C, subjected to fluorescence
microscopy as described in Materials and Methods. Note the intense
flourescence (red stain) in the hepatopancreas compared to the
ovotestis, indicating preferential uptake of the jPEI/fluorecent siRNA
nanoparticles into this tissue.
doi:10.1371/journal.pntd.0001212.g001
Figure 2. Snail organs transfected with or without the
fluorecent siRNA visualized by either light or fluorescence
microscopy. Panels A and C: Images of snail hepatopancreas and
ovotestis tissues of juvenile snails that were either soaked in fluorescent
siRNA (A) for 72 hrs or left untreated (C) viewed without fluorescence
(106 magnification). Panels B and D: The same images of hepatopan-
creas and ovotestis regions shown in panels A and C, subjected to
fluorescence microscopy as described in Materials and Methods. Note
the very weak flourescence (red stain) in the hepatopancreas (B)
indicating less uptake of the fluorescent siRNA into this tissue occurs
without PEI (106magnification).
doi:10.1371/journal.pntd.0001212.g002
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determined by incubation at RT for 30 min with 3-ethylbenzthia-
zoline-6-sulfonate by ABTS Microwell Peroxidase Substrate
System (Kirkegaard&Perry Laboratories, MD), 100 ml/well. The
reaction was stopped with 100 ml of 1% SDS solution, and
absorbance at 405 nm was read by using a microplate reader
(BioRad Laboratories). All assays were done in triplicate and
included the following controls: 1) protein extract incubated with
only buffer (no antibody negative control), 2) buffer only incubated
with antibody (no antigen negative control), Prx recombinant
protein incubated with antibody (positive control). The negative
control using the protein extract without antibody was to eliminate
the possibility that false positive results might occur due to
endogenous peroxidase activity present in the extract that might
interfere with the assay. These data are expressed as end point
titre, with the titre being defined as the highest dilution that
yielded an optical density reading greater than twice the
background values. The titres were calculated after subtracting
the mean absorbance of triplicate wells lacking antigen protein
from the absorbance of triplicate wells containing antigen at each
antibody dilution. In cases where snails were treated with CathB
siRNA or CathB dsRNA commercial rabbit anti-Cathepsin B
Figure 3. Analysis of Cath B gene expression by real time qPCR. (A) Relative expression of Cathepsin B gene in CathB1 siRNA/jPEI,
CathB2siRNA/jet PEI, ‘mock’ CathB siRNA, CathB1siRNA, and PEI treated snails versus untreated snails. Treatments were done at room temperature for
72 hrs. (B) Relative expression of Cathepsin B gene in CathB dsRNA/PEI, Myo dsRNA/PEI, CathB dsRNA, and PEI treated versus untreated juvenile snails.
Treatments were done at room temperature for 72 hrs.
doi:10.1371/journal.pntd.0001212.g003
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Sm31 polyclonal antibody (anti-S.mansoni CathB) were used to
determine changes in this protein in treated compared to
untreated snails.
Results and Discussion
PEI mediates the uptake of fluorescent siRNA into whole
B. glabrata snails
To determine whether PEI can mediate the uptake of siRNA
into the snail, we tested separately, linear PEI (jPEI) and branched
PEI (bPEI) with fluorescent Alexa 555 tagged siRNA, as described
in Materials and Methods. Figure 1 shows images of the snail’s
hepatopancreas and ovotestis regions visualized either under light
(A and C), or fluorescent microscopy (B and D) after snails have
been incubated for either 24 or 72 hrs at room temperature in
fluorescent Alexa siRNA complexed jPEI (Alexa555 siRNA/jPEI
nanoparticles). Images of snails incubated in either fluorescent
Alexa siRNA alone or untreated normal snails (hepatopancreas
and ovotestis regions) also viewed under either light (A and C) or
by fluorescent microscopy (B and D) are shown in Figure 2.
In Figure 1, by using fluorescent microscopy (panels B and D),
we detected dramatic uptake of fluorescent siRNA/jPEI into the
hepatopancreas at 24 and 72 hrs, as shown by the intense
fluorescence (red) in this tissue. By comparing the same image, but
this time under light microscopy (panels A and C) at 24 and
72 hrs, respectively, it was clear that there was comparatively less
fluorescence in the ovotestis. Very little fluorescence was also
detected in the head-foot region (data not shown). Results showing
low fluorescence in the ovotestis, indicating less delivery of siRNA
Figure 4. Analysis of Prx expression by real time qPCR and ELISA. (A) Relative expression of peroxiredoxin gene in Prx dsRNA/PEI, Myo
dsRNA/PEI, Prx dsRNA alone and PEI treated snails versus untreated snails. Treatments were done at room temperature for 72 hrs. (B) Prx protein
suppression analyzed by ELISA as described in Materials and Methods with recombinant B. glabrata Prx antibody. Each bar represents the geometric
mean end point titre 6 standard error (SE) of each experimental group as indicated on the y-axis.
doi:10.1371/journal.pntd.0001212.g004
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multiple (610) experiments and are consistent with other studies.
Thus, in linear PEI-mediated delivery of DNA in the mouse, Zou
et al. [31] detected uptake of the complex essentially in the liver
and lungs but not in other organs.
Figure 2 shows images of the hepatopancreas and ovotestis
regions of snails that were treated for 72 hrs with the fluorescent
siRNA alone (control without PEI) viewed either by light (panel A)
or fluorescence microscopy (panel B). Results showed that in the
absence of the PEI carrier, only weak fluorescence was detected in
the hepatopancreas of this snail. Images in panels C and D of
Figure 2 correspond to the hepatopancreas and ovotestis regions of
the untreated snail viewed either by light (panel C) or fluorescent
(panel D) microscopy. The absence of fluorescence in the control
snail in addition to the weak fluorescence detected in snails
incubated only with the naked fluorescent siRNA, without PEI
(Fig. 2, panel B), supports the conclusion that this carrier mediates
the uptake of fluorescence siRNA into the body of the snail by
soaking. We have as yet no explanation for how this uptake
penetrates the snail’s mucus barrier. Additionally, we cannot rule
out the possibility that some of the PEI/siRNA nanoparticles
might be ingested/swallowed by the snail. Similar intense
fluorescence accumulation in the hepatopancreas relative to other
tissues was observed by using bPEI instead of jPEI for the delivery
(data not shown).
Cathepsin B siRNA and dsRNA-PEI mediated knockdown
of the corresponding snail transcript
To determine if the delivery protocol developed with fluorescent
siRNA (Alexa 555)/PEI nanoparticles can be utilized to target the
specific knockdown of a known snail gene we obtained synthetic
siRNA designed from different regions of the CathB transcript.
We chose siRNA corresponding to conserved regions denoting the
propeptide C1 region (siCathB1) and known consensus active site
(siCathB2) of this enzyme. PEI complexes of different Cath B
siRNA or Cath B dsRNA were tested in a ‘proof of principle’
study, for knockdown of the corresponding CathB transcript.
Results showed a knockdown of the CathB transcript; 45.9% and
55.61% suppression (statistically significant differences between
the normal snail and other control groups were shown by One-
Way ANOVA analysis [P value,0.01]) in snails soaked in the
CathB1 siRNA/PEI (Fig. 3a) and CathB dsRNA/PEI (Fig.3b)
complexes, respectively. In snails soaked in the siCathB2/PEI
complex, however, knockdown was found to be less than when the
siCathB1/PEI complex was delivered into the snail. This result
was unexpected, especially since the commercially purchased
siCathB2 encompasses the catalytic region of the enzyme. Other
siRNAs designed specifically from the active site of the snail
enzyme sequence will be tested in future studies to resolve this
unexpected result. In the other snails, no knockdown effect was
observed in those treated either with siCathB1 alone (without PEI)
or those treated only with PEI. Likewise, the CathB transcript in
snails soaked in mock siRNA/PEI remained at about the same
level (99.3%) as the level detected in the normal snail (100%).
Similarly, as shown in Figure 3b, control snails soaked in naked
CathB dsRNA, Myo dsRNA/PEI complexes, and the PEI carrier
alone produced no significant knockdown of the CathB transcript.
Soaking Prx dsRNA with PEI carrier knocks down the
corresponding snail transcript and protein
To further evaluate the usefulness of the PEI-complex whole
organism soaking method, studies were performed with dsRNA
corresponding to another previously characterized snail gene, Prx
[21]. As shown in Figure 4a, soaking the snails in the B. glabrata
Prx-dsRNA/PEI complex produced a significant knockdown (70%
suppression) of the Prx transcript. In contrast, there was no
reduction of the transcript in snails that were soaked in mock Myo
dsRNA/PEI, Prx-dsRNA, and PEI alone. The level of transcript
in these samples remained almost unchanged, and was compara-
ble to the basal level of the Prx transcript in the normal snail.
To determine whether the above delivery of Prx-dsRNA/PEI
complexes would result in the successful suppression of the Prx
protein as well, by using ELISA (Fig. 4b), we detected dramatic
knockdown of the protein in snails soaked in this complex. The
protein suppression observed in Prx dsRNA/PEI treated snails
analyzed by one-way ANOVA was statistically significant (P
value,0.05). Suppression at the protein level was between end-
point ELISA titre 800–1,600, compared to either the normal or
control groups (end-point ELISA titer between 25,600–51,200).
End point titre observed in snails treated with the Prx-dsRNA/PEI
complex, reflected a significant reduction in the Prx protein in
these snails compared to control snails that were soaked in mock
myo-dsRNA/PEI, naked Prx dsRNA, and PEI. Similar ELISA
experiments conducted using either commercially available, or S.
mansoni anti-CathB antibodies showed no cross reaction between
the snail CathB homolog and both these reagents. Therefore,
investigations to assess the possible knockdown of Cath B
transcript, at the protein level, will have to wait for the future
generation of specific antibodies for the snail CathB enzyme. In
addition, future studies will be done to examine suppression of the
enzyme activities of Prx and CathB in order to evaluate whether
the demonstrated PEI mediated knockdown of these transcripts
translates into disrupting the function of these enzymes as well.
Figure 5. Time course for optimum gene knockdown after soaking snails in either dsRNA/PEI or siRNA/PEI nanoparticles. (A) Relative
expression of Cathepsin B gene in juvenile snails soaked for between 1 and 4 days in CathB dsRNA/PEI. (B) Relative expression of peroxiredoxin gene
in snails soaked for between 1 and 4 days in Prx dsRNA/PEI. (C) Relative expression of Cathepsin B gene in snails soaked for 1 to 4 days in CathB1-
siRNA/PEI. Note in all time course studies that the optimum knockdown of transcripts occurs at day 3 of incubating in either dsRNA/PEI or siRNA/PEI
complexes.
doi:10.1371/journal.pntd.0001212.g005
Figure 6. Survival of juvenile snails treated with PEI. Percentage
survival of juvenile snails (n=117) soaked in PEI compared to untreated
control snails (n=29).
doi:10.1371/journal.pntd.0001212.g006
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siRNA into pre-patent snails enabled the detection of fluorescent
labeled sporocysts in the infected snails (data not shown). We have
as yet, however, no evidence that our PEI delivery protocol will
provide a useful avenue for targeting specific sporocyst (parasite)
genes for silencing. Initial attempts to use the PEI delivery protocol
for siRNA delivery in miracidia have so far been unsuccessful.
PEI is non-toxic in juvenile B. glabrata snails
In the present study we found that soaking the snails for 1 to 4
days in either dsRNA/PEI or siRNA/PEI resulted in gene
suppression within the first 24 hours that extended to 4 days post-
treatment (Fig. 5). Thus, in Figures 5a and 5b, we detected
significant knockdown of CathB and Prx after 2 and 3 days of
soaking in dsRNA/PEI nanoparticles. Similarly, optimum knock-
down of CathB occurred following 2 and 3 days of soaking in the
siRNACathB/PEI complex (Fig. 5c). These results also showed
that after 4 days of soaking, in either dsRNA/PEI or siRNA/PEI,
a recovery from the treatment began to occur, indicating,
therefore, that the time period for achieving optimum knockdown
(using the conditions we employed) occurs 72 hrs after snails have
been soaked in the complexes. Furthermore, we detected no
mortality under the conditions utilized even though the snails
remained in PEI for as long as 4 days. Thus, results in Figure 6
shows the 100% survival of snails (n=117) treated with PEI versus
untreated snails (n=29), indicating that the cationic polymer (both
linear and branched) was non-toxic at the concentration utilized in
the protocol.
Comparable uptake of siRNA/PEI into adult snails was not
examined as part of this work because our current research is
primarily focused on elucidating the molecular basis of the more
vulnerable juvenile snail host’s relationship with the parasite. Since
our previous attempts to introduce dsRNA into juvenile snails via
an injection route produced either inconsistent results or killed the
snails, the pressing need for us, therefore, was to develop a reliable
and safe gene-silencing tool specifically for snails at this young age
and not for adult snails.
By complexing either siRNA or dsRNA to the cationic PEI
polymers we have shown in the present study that it is possible to
obtain significant knockdown of specific snail transcripts, at both
RNA and protein levels, by whole organism soaking. As stated
above, most previous studies using RNAi technology in snails have
used an injecting route for delivery [7,8]. The injection method
can, however, be cumbersome for an inexperienced investigator,
making a straightforward dsRNA delivery method for snails
(especially juveniles) until now very challenging and impractical.
For this reason, while functional gene analysis with RNAi
technology is now used routinely in several organisms, including
schistosomes [11] very few molecular functional studies using
RNAi have been reported for molluscs. With several genome
projects for mollusks now underway, including the B. glabrata
genome project [6] the need for an easier and more convenient
dsRNA delivery approach for future functional genomic studies in
these organisms is overdue. The simplicity of the method
described here, paves the way as a first step towards overcoming
the challenges faced in using RNAi technology routinely in
mollusks.
The PEI soaking method was optimized and evaluated using
two snail transcripts (Cathepsin B and peroxiredoxin) that we have
previously shown to be expressed, preferentially in the snail’s
hepatopancreas. Both genes are also early and more significantly
induced in the resistant B. glabrata snail stock, BS-90, compared to
the susceptible NMRI snail, in response to S. mansoni exposure
[20,21]. With the PEI mediated siRNA and dsRNA gene silencing
method developed, we now have the ability to systematically
determine the effect of down regulating CathB and Prx as well as
other transcripts in the dynamic interplay of the snail- schistosome
interaction. Our results showed that the majority of the fluorescent
siRNA/PEI complex was detected in the hepatopancreas. It is
possible, therefore, that we might have been able to knock- down
the two transcripts we chose easily because they are also expressed
preferentially in this tissue. In any case, even if limited to this tissue
the ability to use a simple and effective whole organism soaking
method to conveniently knockdown specific genes in B. glabrata by
RNAi technology is an important first step in using this proven
gene-silencing tool for snail molecular research.
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